NZ710361A - Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities - Google Patents
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activitiesInfo
- Publication number
- NZ710361A NZ710361A NZ710361A NZ71036114A NZ710361A NZ 710361 A NZ710361 A NZ 710361A NZ 710361 A NZ710361 A NZ 710361A NZ 71036114 A NZ71036114 A NZ 71036114A NZ 710361 A NZ710361 A NZ 710361A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hydroxyquinolin
- derivatives
- salts
- hydroxyethyl
- amino
- Prior art date
Links
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 title abstract 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title abstract 2
- 239000000048 adrenergic agonist Substances 0.000 title abstract 2
- 229940126157 adrenergic receptor agonist Drugs 0.000 title abstract 2
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- JKMZVSFWKKXBGL-UHFFFAOYSA-N NCC(O)N1C(C=CC2=CC=CC(=C12)O)=O Chemical class NCC(O)N1C(C=CC2=CC=CC(=C12)O)=O JKMZVSFWKKXBGL-UHFFFAOYSA-N 0.000 title 1
- 239000003149 muscarinic antagonist Substances 0.000 title 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- ZXZKYYHTWHJHFT-UHFFFAOYSA-N quinoline-2,8-diol Chemical class C1=CC(=O)NC2=C1C=CC=C2O ZXZKYYHTWHJHFT-UHFFFAOYSA-N 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13382060 | 2013-02-27 | ||
US201361804558P | 2013-03-22 | 2013-03-22 | |
PCT/EP2014/053871 WO2014131851A1 (en) | 2013-02-27 | 2014-02-27 | SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH β2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ710361A true NZ710361A (en) | 2020-05-29 |
Family
ID=67180452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ710361A NZ710361A (en) | 2013-02-27 | 2014-02-27 | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities |
Country Status (4)
Country | Link |
---|---|
CY (1) | CY1120279T1 (es) |
NI (1) | NI201500107A (es) |
NZ (1) | NZ710361A (es) |
SV (1) | SV2015005045A (es) |
-
2014
- 2014-02-27 NZ NZ710361A patent/NZ710361A/en not_active IP Right Cessation
-
2015
- 2015-08-14 NI NI201500107A patent/NI201500107A/es unknown
- 2015-08-26 SV SV2015005045A patent/SV2015005045A/es unknown
-
2018
- 2018-05-25 CY CY20181100566T patent/CY1120279T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
NI201500107A (es) | 2017-03-13 |
CY1120279T1 (el) | 2019-07-10 |
SV2015005045A (es) | 2018-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015501754A1 (en) | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both �2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities | |
PH12016500125A1 (en) | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both muscarinic receptor antagonist and �2 adrenergic receptor agonist activities | |
MY169479A (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
UA111640C2 (uk) | ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2 | |
MA40170A (fr) | Dérivés hétérocycliques de morphinan et leur utilisation | |
MX350419B (es) | Compuesto (tieno [2,3-b] [1,5] benzoxazepin -4 -il) piperazin- 1 - ilo como angonistas inversos h1/antagonistas 5 -ht2a de actividad doble. | |
EA201370149A1 (ru) | Антагонисты рецептора | |
MX360699B (es) | Derivados de espiro [2.4] heptano puenteado substituidos por piperazina, utilizados como agonistas del receptor alx. | |
MX2015017541A (es) | Derivados de espiro [2.4] heptano puenteados sustituidos con difluoroetil-oxazol como agonistas del receptor de alx. | |
EA201391706A1 (ru) | Соединения (тиено[2,3-b][1,5]бензоксазепин-4-ил)пиперазин-1-ила в качестве соединений, обладающих двойной активностью обратных агонистов h1/антагонистов 5-ht | |
NZ710361A (en) | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities | |
EA201390966A1 (ru) | Замещенные соединения [(5h-пирроло[2,1-c][1,4]бензодиазепин-11-ил)пиперазин-1-ил]-2,2-диметилпропановой кислоты в качестве обратных агонистов h1/антагонистов 5-htдвойного действия | |
EA201591099A1 (ru) | ТИЕНО([2,3-b][1,5]БЕНЗОКСАЗЕПИН-4-ИЛ)ПИПЕРАЗИН-1-ИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ АГЕНТОВ С ДВОЙНОЙ АКТИВНОСТЬЮ: ОБРАТНЫХ АГОНИСТОВ H1/АНТАГОНИСТОВ 5-HT | |
TH163971A (th) | เกลือของอนุพันธ์ 2-อะมิโน-1-ไฮดรอกซีเอทริล-8-ไฮดรอกซีควิโนลิน-2-(1H)-โอน(2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one) ซึ่งมีทั้งฤทธิ์มัสคารินิก รีเซพเตอร์แอนทาโกนิสและฤทธิ์ (เบต้า)2 อะดรีเนอร์จิกรีเซพเตอร์อะโกนิสต์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 FEB 2022 BY COMPUTER PACKAGES INC Effective date: 20210130 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 FEB 2023 BY COMPUTER PACKAGES INC Effective date: 20220130 |
|
LAPS | Patent lapsed |